Compass Therapeutics Inc.
CMPX | NASDAQ
$1.25
-$0.57 (-31.32%)
Sep 22, 2026, 9:33 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -12.79 | -4.03 | -4.73 | -14.37 | -2.42 | -16.35 |
PEG Ratio | -0.77 | -0.44 | 0.83 | 0.20 | -0.02 | 0.73 |
PS Ratio | n/a | 233.89 | n/a | n/a | n/a | n/a |
PB Ratio | 4.30 | 1.59 | 1.33 | 2.91 | 1.42 | 11.96 |
P/FCF Ratio | -17.22 | -4.43 | -4.88 | -15.41 | -9.39 | -17.76 |
P/OCF Ratio | -17.23 | -4.43 | -4.88 | -15.50 | -10.13 | -17.83 |
OCF/S Ratio | n/a | -5.28K | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 0.05 | 0.05 | 0.01 | 0.02 | 0.03 | 0.23 |
Quick Ratio | 15.02 | 14.96 | 19.73 | 12.05 | 13.84 | 4.97 |
Current Ratio | 15.02 | 14.96 | 19.73 | 12.05 | 13.84 | 4.97 |
Asset Turnover | n/a | 0.01 | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | n/a | n/a | -17.65 | -221.30 | -30.63 |
Return on Equity | -33.79% | -39.43% | -28.61% | -21.60% | -58.67% | -73.85% |
Return on Assets | -30.28% | -35.17% | -27.09% | -19.65% | -53.45% | -56.83% |
Return on Invested Capital | -35.25% | -42.94% | -33.51% | -22.57% | -56.82% | -56.44% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | 100% | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | -5.81K% | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | -5.81K% | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | -6.66K% | n/a | n/a | n/a | n/a |
FCF Margin | n/a | -5.28K% | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | -5.6K% | n/a | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove CMPX